OraSure Technologies Total Assets 2010-2025 | OSUR

OraSure Technologies total assets from 2010 to 2025. Total assets can be defined as the sum of all assets on a company's balance sheet.
OraSure Technologies Annual Total Assets
(Millions of US $)
2024 $480
2023 $483
2022 $444
2021 $461
2020 $454
2019 $349
2018 $316
2017 $296
2016 $208
2015 $189
2014 $190
2013 $184
2012 $191
2011 $128
2010 $123
2009 $127
OraSure Technologies Quarterly Total Assets
(Millions of US $)
2025-06-30 $445
2025-03-31 $458
2024-12-31 $480
2024-09-30 $464
2024-06-30 $466
2024-03-31 $468
2023-12-31 $483
2023-09-30 $458
2023-06-30 $454
2023-03-31 $459
2022-12-31 $444
2022-09-30 $432
2022-06-30 $429
2022-03-31 $436
2021-12-31 $461
2021-09-30 $456
2021-06-30 $465
2021-03-31 $456
2020-12-31 $454
2020-09-30 $436
2020-06-30 $421
2020-03-31 $325
2019-12-31 $349
2019-09-30 $339
2019-06-30 $327
2019-03-31 $319
2018-12-31 $316
2018-09-30 $304
2018-06-30 $292
2018-03-31 $286
2017-12-31 $296
2017-09-30 $282
2017-06-30 $258
2017-03-31 $233
2016-12-31 $208
2016-09-30 $204
2016-06-30 $200
2016-03-31 $188
2015-12-31 $189
2015-09-30 $194
2015-06-30 $180
2015-03-31 $178
2014-12-31 $190
2014-09-30 $191
2014-06-30 $180
2014-03-31 $174
2013-12-31 $184
2013-09-30 $178
2013-06-30 $174
2013-03-31 $182
2012-12-31 $191
2012-09-30 $197
2012-06-30 $125
2012-03-31 $125
2011-12-31 $128
2011-09-30 $123
2011-06-30 $121
2011-03-31 $119
2010-12-31 $123
2010-09-30 $122
2010-06-30 $124
2010-03-31 $121
2009-12-31 $127
2009-09-30 $128
2009-06-30 $122
2009-03-31 $127
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $0.255B $0.186B
OraSure Technologies, Inc. develops, manufactures and markets oral fluid specimen collection devices using proprietary oral fluid technologies, diagnostic products including immunoassays and other in vitro diagnostic tests, and other medical devices. These products are sold in the United States as well as internationally to various clinical laboratories, hospitals, clinics, community-based organizations and other public health organizations, distributors, government agencies, physicians' offices, and commercial and industrial entities. OraSure Technologies is the leading supplier of oral-fluid collection devices and in vitro diagnostic assays to the employment, criminal justice, drug treatment, life insurance and public health markets for the detection of abused drugs and the antibodies to HIV. Based in Bethlehem, Pennsylvania, the Company develops, manufactures and markets oral specimen collection devices, in vitro diagnostic tests, and other medical devices.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $229.027B 26.85
Boston Scientific (BSX) United States $157.644B 37.59
Stryker (SYK) United States $150.755B 30.69
EssilorLuxottica (ESLOY) France $144.001B 0.00
Medtronic (MDT) Ireland $118.256B 16.67
Lonza Group Ag (LZAGY) Switzerland $50.628B 0.00
Haleon (HLN) United Kingdom $43.188B 24.69
ResMed (RMD) United States $41.753B 29.86
GE HealthCare Technologies (GEHC) United States $33.827B 15.90
Agilent Technologies (A) United States $33.605B 21.91
Koninklijke Philips (PHG) Netherlands $26.779B 17.71
Terumo (TRUMY) Japan $26.532B 31.44
Insulet (PODD) United States $23.358B 78.26
Zimmer Biomet Holdings (ZBH) United States $21.303B 13.56
Smith & Nephew SNATS (SNN) United Kingdom $16.337B 0.00
Baxter (BAX) United States $12.584B 9.72
Sunny Optical Technology (SNPTF) China $10.800B 0.00
Demant (WILYY) Denmark $8.121B 0.00
Bio-Rad Laboratories (BIO) United States $8.027B 29.48
Lantheus Holdings (LNTH) United States $3.785B 10.23
Envista Holdings (NVST) United States $3.513B 24.58
Shandong Weigao Medical Polymer (SHWGF) China $3.459B 0.00
Prestige Consumer Healthcare (PBH) United States $3.268B 14.50
Perrigo (PRGO) Ireland $3.265B 8.15
ICU Medical (ICUI) United States $3.109B 21.17
Haemonetics (HAE) United States $2.661B 11.88
LeMaitre Vascular (LMAT) United States $2.157B 46.25
Acuren (TIC) United States $2.156B 0.00
Curaleaf Holdings (CURLF) Canada $2.117B 0.00
QuidelOrtho (QDEL) United States $1.896B 11.93
Green Thumb Industries (GTBIF) United States $1.888B 81.09
AtriCure (ATRC) United States $1.882B 0.00
Tilray Brands (TLRY) Canada $1.596B 0.00
Phibro Animal Health (PAHC) United States $1.323B 16.91
AdaptHealth (AHCO) United States $1.246B 17.71
BioLife Solutions (BLFS) United States $1.229B 2565.00
Neogen (NEOG) United States $1.223B 19.41
Kestra Medical Technologies (KMTS) United States $0.952B 0.00
InMode (INMD) Israel $0.941B 8.70
Valneva SE (VALN) France $0.762B 0.00
Cresco Labs (CRLBF) United States $0.683B 0.00
SNDL (SNDL) Canada $0.649B 0.00
Maravai LifeSciences Holdings (MRVI) United States $0.618B 0.00
Verano Holdings (VRNOF) United States $0.615B 0.00
ZimVie (ZIMV) United States $0.535B 20.62
Surmodics (SRDX) United States $0.496B 0.00
Evolus (EOLS) United States $0.495B 0.00
VAREX IMAGING (VREX) United States $0.468B 16.11
CeriBell (CBLL) United States $0.420B 0.00
Owens & Minor (OMI) United States $0.387B 3.43
Sanuwave Health (SNWV) United States $0.360B 0.00
Canopy Growth (CGC) Canada $0.353B 0.00
TerrAscend (TSNDF) Canada $0.352B 0.00
SEMPERIT AG HLD (SEIGY) Austria $0.317B 0.00
Brainsway (BWAY) Israel $0.301B 61.15
Sanara MedTech (SMTI) United States $0.300B 0.00
Aurora Cannabis (ACB) Canada $0.299B 0.00
Omeros (OMER) United States $0.298B 0.00
Capricor Therapeutics (CAPR) United States $0.296B 0.00
High Tide (HITI) Canada $0.283B 0.00
Viemed Healthcare (VMD) United States $0.273B 20.74
Cerus (CERS) United States $0.255B 0.00
TriSalus Life Sciences (TLSI) United States $0.254B 0.00
Vireo Growth (VREOF) United States $0.241B 0.00
Organigram Global (OGI) Canada $0.221B 0.00
Quanterix (QTRX) United States $0.218B 0.00
Exagen (XGN) United States $0.218B 0.00
Utah Medical Products (UTMD) United States $0.195B 16.24
FitLife Brands (FTLF) United States $0.173B 21.31
Biote (BTMD) United States $0.164B 5.43
Jushi Holdings (JUSHF) United States $0.151B 0.00
Jin Medical (ZJYL) China $0.130B 0.00
MacroGenics (MGNX) United States $0.114B 0.00
Quipt Home Medical (QIPT) United States $0.114B 0.00
Fonar (FONR) United States $0.096B 12.32
Oramed Pharmaceuticals (ORMP) United States $0.087B 0.00
Apyx Medical (APYX) United States $0.079B 0.00
Agape ATP (ATPC) $0.068B 0.00
Safety Shot (SHOT) United States $0.065B 0.00
Cytosorbents (CTSO) United States $0.058B 0.00
ImmuCell (ICCC) United States $0.057B 32.90
Veru (VERU) United States $0.051B 0.00
Zynex (ZYXI) United States $0.050B 0.00
Nephros (NEPH) United States $0.043B 33.67
Rockwell Medical (RMTI) United States $0.043B 0.00
Modular Medical (MODD) United States $0.041B 0.00
United-Guardian (UG) United States $0.038B 14.62
Trinity Biotech (TRIB) Ireland $0.027B 0.00
Senestech (SNES) United States $0.023B 0.00
INLIF (INLF) $0.018B 0.00
Allurion Technologies (ALUR) United States $0.016B 0.00
Cellectar Biosciences (CLRB) United States $0.015B 0.00
Meihua Medical Technologies (MHUA) China $0.014B 0.00
Flora Growth (FLGC) United States $0.013B 0.00
IM Cannabis (IMCC) Canada $0.012B 0.00
Sharps Technology (STSS) United States $0.010B 0.00
Innovative Eyewear (LUCY) United States $0.007B 0.00
GlucoTrack (GCTK) United States $0.004B 0.00
Akanda (AKAN) Canada $0.002B 0.00
InterCure (INCR) Israel $0.000B 0.00
InVivo Therapeutics Holdings (NVIVQ) United States $0.000B 0.00